Evidence map›Paper›PMID 21887277›Full record

ArticlePloS one2011

Serum-nutrient starvation induces cell death mediated by Bax and Puma that is counteracted by p21 and unmasked by Bcl-x(L) inhibition.

Frédérique Braun, Joséphine Bertin-Ciftci, Anne-Sophie Gallouet, Julie Millour, Philippe Juin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Controlled Release of HBiomacromolecules · 2023
    Article
  6. SimulatedPostepy dermatologii i alergologii · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. How Far Are We from Prescribing Fasting as Anticancer Medicine?International journal of molecular sciences · 2020
    Review
  12. Article
  13. Article
  14. Optimization of recombinant Zika virus NS1 protein secretion from HEK293 cells.Biotechnology reports (Amsterdam, Netherlands) · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Dietary restriction: could it be considered as speed bump on tumor progression road?Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Frédérique BraunCentre de Recherche en Cancérologie Nantes Angers, Institut National de la Santé et de la Recherche Médicale UMR 892/Université de Nantes, Nantes, France. frederique.braun@univ-nantes.fr
Joséphine Bertin-Ciftci
Anne-Sophie Gallouet
Julie Millour
Philippe Juin
Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cyclin-dependent kinase inhibitor p21 (p21WAF1/Cip1) is a multifunctional protein known to promote cell cycle arrest and survival in response to p53-dependent and p53 independent stimuli. We herein investigated whether and how it might contribute to the survival of cancer cells that are in low-nutrient conditions during tumour growth, by culturing isogenic human colorectal cancer cell lines (HCT116) and breast cancer cell lines in a medium deprived in amino acids and serum. We show that such starvation enhances, independently from p53, the expression of p21 and that of the pro-apoptotic BH3-only protein Puma. Under these conditions, p21 prevents Puma and its downstream effector Bax from triggering the mitochondrial apoptotic pathway. This anti-apoptotic effect is exerted from the cytosol but it is unrelated to the ability of p21 to interfere with the effector caspase 3. The survival function of p21 is, however, overcome by RNA interference mediated Bcl-x(L) depletion, or by the pharmacological inhibitor ABT-737. Thus, an insufficient supply in nutrients may not have an overt effect on cancer cell viability due to p21 induction, but it primes these cells to die, and sensitizes them to the deleterious effects of Bcl-x(L) inhibitors regardless of their p53 status.

Indexed as

Apoptosis Regulatory Proteinsbcl-2-Associated X Proteinbcl-X ProteinCaspase 3Cell DeathCell SurvivalCyclin-Dependent Kinase Inhibitor p21CytoplasmCytoprotectionDown-RegulationHCT116 CellsHumansProtein BindingProtein TransportProto-Oncogene ProteinsSerumApoptosis Regulatory ProteinsBBC3 protein, humanbcl-2-Associated X Proteinbcl-X ProteinCaspase 3Cyclin-Dependent Kinase Inhibitor p21Proto-Oncogene ProteinsTumor Suppressor Protein p53

Identifiers

PMID21887277
PMCPMC3160893
OpenAlexW2072904998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.